Part, Chapter, Paragraph
1 I, 3. 3 | importance when considering the financing of long-term care.~ ~These
2 II, 5. 7. 7| Health Care Organization and Financing for renal replacement therapy
3 II, 5. 14. 2| private and public health care financing agencies, and decision-makers
4 II, 9. 3. 2| even lower. Legislation, financing (public/private insurance/
5 IV, 11. 1. 1| dimensions: generating resources; financing; providing services; and
6 IV, 11. 1. 1| encompass health status, fair financing, and responsiveness. While
7 IV, 11. 1. 1| provision, resources and financing of health systems in the
8 IV, 11. 1. 1| The last part examines the financing of health care, including
9 IV, 11. 1. 1| expenditure, sources of financing, progressiveness of funding
10 IV, 11. 1. 2| areas such as sources of financing, waiting times, provider
11 IV, 11. 1. 3| through a combination of financing and organization characteristics.
12 IV, 11. 1. 3| population, and fairness of financing. The report further delineates
13 IV, 11. 1. 3| provision, resource generation, financing and stewardship. One of
14 IV, 11. 1. 4| 2003) (see Section 11.6 on Financing health care). Organizational
15 IV, 11. 1. 6| outcomes of health system financing. Specifically, these payment
16 IV, 11. 1. 6| even when implemented for financing purposes, their objectives
17 IV, 11. 1. 6| objectives reach beyond financing to other aims such as increased
18 IV, 11. 1. 6| impact of the DRG hospital financing systems introduced in Europe
19 IV, 11. 1. 6| regulation (see Section 11.6 Financing Health Care). In the Central
20 IV, 11. 1. 6| have embarked on healthcare financing reforms, the separation
21 IV, 11. 2. 1| characteristics such as financing, resource allocation and
22 IV, 11. 3 | factors relating to the financing, organization, regulation
23 IV, 11. 3. 2| heavily on private sources of financing. Public expenditure on pharmaceuticals
24 IV, 11. 6 | 11.6. Financing healthcare~ ~This section
25 IV, 11. 6. 1| options of pursuing deficit financing (not a realistic option
26 IV, 11. 6. 2| and assessment of health financing systems~ ~Health financing
27 IV, 11. 6. 2| financing systems~ ~Health financing consists of three main functions:
28 IV, 11. 6. 2| affecting the three main financing functions – such as changes
29 IV, 11. 6. 2| the basis of the health financing goals outlined by the WHO:
30 IV, 11. 6. 2| financial protection, equity in financing, equity of access, transparency
31 IV, 11. 6. 2| was a shift away from tax financing to employment related insurance
32 IV, 11. 6. 2| achieve the goals of health financing. Finally, the definition
33 IV, 11. 6. 2| Collecting funds~ ~The sources of financing include individuals or households
34 IV, 11. 6. 2| countries, the role of private financing has increased over the last
35 IV, 11. 6. 2| minor role in healthcare financing in Europe, although it appears
36 IV, 11. 6. 2| payments represent an important financing source in many countries (
37 IV, 11. 6. 2| Key reforms to the overall financing systems in Europe have been
38 IV, 11. 6. 2| to the system of health financing was also seen in the Netherlands,
39 IV, 11. 6. 2| insurance funds.~ ~Table 11.12. Financing mix separated by public
40 IV, 11. 6. 2| of indirect taxes in the financing system thus has a significant
41 IV, 11. 6. 2| fact a large driver for the financing reforms in France in the
42 IV, 11. 6. 2| significant changes to the Dutch financing system. This Law replaces
43 IV, 11. 6. 3| One study of healthcare financing in OECD countries found
44 IV, 11. 6. 3| more progressive system of financing than local taxation. For
45 IV, 11. 6. 3| insurance, this will make the financing system more progressive,
46 IV, 11. 6. 3| change in progressiveness of financing in the transition countries
47 IV, 11. 6. 3| be estimated that health financing in this region has become
48 IV, 11. 6. 3| of fairness of healthcare financing. This formula is based on
49 IV, 11. 6. 3| Thus, a fair system of financing would be one where the ratio
50 IV, 11. 6. 3| country with the fairest financing system appears to be Slovakia,
51 IV, 11. 6. 4| maintained in theory, inadequate financing and informal payments have
52 IV, 11. 6. 5| distributional impact of health financing in Europe: a review. Oxford,
53 IV, 11. 6. 5| Federation (2006): DRGs as a financing tool. Brussels, HOPE.~ ~
54 IV, 11. 6. 5| distributional changes in health care financing in Finland." Journal of
55 IV, 11. 6. 5| M et al. (2002): Health financing reforms in central and Eastern
56 IV, 11. 6. 5| HTA in the European Union. Financing Sustainable Healthcare in
57 IV, 12. 5 | utilisation~Health expenditure and financing~Health care quality/performance~ ~
58 IV, 13. 5 | share of private sources of financing must not hinder accessibility
59 IV, 13. 5 | Measures include changes in the financing mechanisms, but secure financing
60 IV, 13. 5 | financing mechanisms, but secure financing of long-term care is yet
61 Key, Ap5. 0. 0| fibrosis~filariasis~filoviridae~financing~Finland~fish~flavourings~
